Calithera Biosciences
Calithera Biosciences, a clinical‑stage biopharma formerly focused on glutaminase and arginase inhibitors for cancer and other diseases, advanced CB‑839 to Phase II and partnered with Pfizer, Incyte, and Mars on oncology drug candidates.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 8
- HQ: South San Francisco
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.